Additionally, hsa-miR-16-5p could specifically regulate four hub target genes (MCL1, AP2B1, LAMB1, and RAB11FIP2), and their methylation states, thereby predicted to affect the prognoses of patients with GC. Here, LAMB1 is linked to gastric cancer.